Literature DB >> 15236429

Advantages to transforming the receiver operating characteristic (ROC) curve into likelihood ratio co-ordinates.

Nils P Johnson1.   

Abstract

Traditionally, the receiver operating characteristic (ROC) curve for a diagnostic test plots true positives (sensitivity) against false positives (one minus specificity). However, this representation brings with it several drawbacks. A transformation to positive and negative likelihood ratio co-ordinates, scaled by base-ten logarithms, offers several advantages. First we motivate the use of positive and negative likelihood ratios, emphasizing their relationship to modification of the odds ratio. Then we highlight properties of likelihood ratios using the traditional ROC axes. Finally, we demonstrate ROC curves and their properties after conversion to likelihood ratio co-ordinates. These graphs do not waste space for tests lacking diagnostic power, and offer a simple visual assessment of a test's impact on the odds ratio. Copyright 2004 John Wiley & Sons, Ltd.

Mesh:

Year:  2004        PMID: 15236429     DOI: 10.1002/sim.1835

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  The utility of the Kessler Screening Scale for Psychological Distress (K6) in two American Indian communities.

Authors:  Christina M Mitchell; Janette Beals
Journal:  Psychol Assess       Date:  2011-09

2.  Novel protein candidates for serodiagnosis of African animal trypanosomosis: Evaluation of the diagnostic potential of lysophospholipase and glycerol kinase from Trypanosoma brucei.

Authors:  Magamba Tounkara; Alain Boulangé; Magali Thonnus; Frédéric Bringaud; Adrien Marie Gaston Bélem; Zakaria Bengaly; Sophie Thévenon; David Berthier; Loïc Rivière
Journal:  PLoS Negl Trop Dis       Date:  2021-12-17

3.  Analytical detection of immunoglobulin heavy chain gene rearrangements in gastric lymphoid infiltrates by peak area analysis of the melting curve in the LightCycler System.

Authors:  Eduardo Retamales; Luis Rodriguez; Leda Guzman; Francisco Aguayo; Mariana Palma; Claudia Backhouse; Jorge Argandona; Erick Riquelme; Alejandro Corvalan
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

4.  The serodiagnostic potential of recombinant proteins TES-30 and TES-120 in an indirect ELISA in the diagnosis of toxocariasis in cattle, horses, and sheep.

Authors:  Lucas Moreira Dos Santos; Rafael Amaral Donassolo; Maria Elisabeth Berne; Fábio Pereira Leivas Leite; Luciana Farias da Costa Avila; Carlos James Scaini; Ângela Nunes Moreira; Fabricio Rochedo Conceição
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

5.  Congo Red Dot Paper Test for Antenatal Triage and Rapid Identification of Preeclampsia.

Authors:  Kara M Rood; Catalin S Buhimschi; Theresa Dible; Shaylyn Webster; Guomao Zhao; Philip Samuels; Irina A Buhimschi
Journal:  EClinicalMedicine       Date:  2019-03-01

6.  Information Graphs Incorporating Predictive Values of Disease Forecasts.

Authors:  Gareth Hughes; Jennifer Reed; Neil McRoberts
Journal:  Entropy (Basel)       Date:  2020-03-20       Impact factor: 2.524

7.  Predictive modeling for diagnostic tests with high specificity, but low sensitivity: a study of the glycerol test in patients with suspected Menière's disease.

Authors:  Bernd Lütkenhöner; Türker Basel
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

8.  Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke.

Authors:  Leonardo Lorente; María M Martín; Teresa Almeida; Antonia Pérez-Cejas; Luis Ramos; Mónica Argueso; Marta Riaño-Ruiz; Jordi Solé-Violán; Mariano Hernández
Journal:  Int J Mol Sci       Date:  2016-06-22       Impact factor: 5.923

9.  Profiling neuronal ion channelopathies with non-invasive brain imaging and dynamic causal models: Case studies of single gene mutations.

Authors:  Jessica R Gilbert; Mkael Symmonds; Michael G Hanna; Raymond J Dolan; Karl J Friston; Rosalyn J Moran
Journal:  Neuroimage       Date:  2015-09-03       Impact factor: 6.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.